1 |
Gupta Y, Savytskyi OV, Coban M, Venugopal A, Pleqi V, Weber CA, Chitale R, Durvasula R, Hopkins C, Kempaiah P, Caulfield TR. Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics. Mol Aspects Med 2022;91:101151. [PMID: 36371228 DOI: 10.1016/j.mam.2022.101151] [Reference Citation Analysis]
|
2 |
Españo E, Kim JK. Effects of Statin Combinations on Zika Virus Infection in Vero Cells. Pharmaceutics 2022;15. [PMID: 36678679 DOI: 10.3390/pharmaceutics15010050] [Reference Citation Analysis]
|
3 |
Urueña C, Ballesteros-ramírez R, Gomez-cadena A, Barreto A, Prieto K, Quijano S, Aschner P, Martínez C, Zapata-cardona MI, El-ahanidi H, Jandus C, Florez-alvarez L, Rugeles MT, Zapata-builes W, Garcia AA, Fiorentino S. Randomized double-blind clinical study in patients with COVID-19 to evaluate the safety and efficacy of a phytomedicine (P2Et). Front Med 2022;9. [DOI: 10.3389/fmed.2022.991873] [Reference Citation Analysis]
|
4 |
Fiore D, Proto MC, Franceschelli S, Pascale M, Bifulco M, Gazzerro P. In Vitro Evidence of Statins’ Protective Role against COVID-19 Hallmarks. Biomedicines 2022;10:2123. [DOI: 10.3390/biomedicines10092123] [Reference Citation Analysis]
|
5 |
Lasica R, Djukanovic L, Mrdovic I, Savic L, Ristic A, Zdravkovic M, Simic D, Krljanac G, Popovic D, Simeunovic D, Rajic D, Asanin M. Acute Coronary Syndrome in the COVID-19 Era-Differences and Dilemmas Compared to the Pre-COVID-19 Era. J Clin Med 2022;11:3024. [PMID: 35683411 DOI: 10.3390/jcm11113024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|